This HTML5 document contains 135 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n10http://dx.doi.org/10.1176/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36611362
rdf:type
wikibase:Item
schema:description
artikulong pang-agham мақолаи илмӣ 2013年論文 wissenschaftlicher Artikel 2013年论文 articolo scientifico জানুয়ারি ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научна статия scientific article published on January 2013 2013年論文 article scientifique artículo científico publicado en 2013 სამეცნიერო სტატია scienca artikolo artigo científico 2013年论文 wetenschappelijk artikel bilimsel makale 2013년 논문 naučni članak научни чланак vetenskaplig artikel vědecký článek 2013年论文 bài báo khoa học 2013年論文 научни чланак наукова стаття, опублікована в січні 2013 videnskabelig artikel научная статья 2013年論文 scientific article published on January 2013 artykuł naukowy artigo científico tudományos cikk tieteellinen artikkeli vitskapeleg artikkel 2013年论文 2013 nî lūn-bûn מאמר מדעי artikull shkencor 2013年の論文 مقالة علمية نشرت في يناير 2013 2013年論文 teaduslik artikkel articol științific article scientific 2013年论文 article científic artigo científico vitenskapelig artikkel artículu científicu espublizáu en 2013 2013年论文 vedecký článok scientific article published on January 2013 գիտական հոդված հրատարակված 2013 թվականի հունվարին artikel ilmiah επιστημονικό άρθρο บทความทางวิทยาศาสตร์
p:P577
wds:Q36611362-1A0CB522-045B-4EF8-9C92-24AFE7A9BB8A
wdt:P577
2013-01-01T00:00:00Z
p:P2860
wds:Q36611362-05D92965-9E4A-42A3-915E-B6A6205C3549 wds:Q36611362-0D90BDFF-98DF-4425-BEC7-2E9847682613 wds:Q36611362-1B3D0158-46E2-4B25-8179-D1CE047D7A81 wds:Q36611362-1D31426E-009A-4D34-BCB4-21B13E880740 wds:Q36611362-1F16D536-60B4-4CEA-B192-EF4943BC2500 wds:Q36611362-4B579F82-25D0-4B20-8F3C-140057242402 wds:Q36611362-588AB675-C8C6-411E-B20D-D09E479A447A wds:Q36611362-65F5F9A2-619C-4BF3-9219-B4B616633F95 wds:Q36611362-7724C9DB-510C-4D6A-A462-8D0F1CC132AF wds:Q36611362-7DECE571-1957-4481-812F-D3CD126C24A9 wds:Q36611362-A821D336-89CD-4B39-BD47-D9EAB5E5A3DB wds:Q36611362-B29F4E81-C9F0-489A-AD7F-55899D4CC167 wds:Q36611362-BEB2FEE6-F708-4AE4-8AA7-CF94D8F78295 wds:Q36611362-C225C0CF-713C-421A-939E-8E4DFB2D013A wds:Q36611362-FF01DF01-2DBD-4B9C-874E-CE40EAAED414
wdt:P2860
wd:Q33874154 wd:Q46217322 wd:Q37485253 wd:Q28273164 wd:Q80528323 wd:Q40422597 wd:Q44309866 wd:Q74555036 wd:Q34293049 wd:Q37456318 wd:Q35569720 wd:Q34338807 wd:Q43202669 wd:Q37285493 wd:Q35955153
rdfs:label
Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophrenia Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophrenia Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophrenia
skos:prefLabel
Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophrenia Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophrenia Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophrenia
schema:name
Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophrenia Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophrenia Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophrenia
p:P50
wds:Q36611362-F4B73B84-5272-4289-A13D-E32DBDC65C68 wds:Q36611362-D02E3952-2471-4196-985C-9AA5AE0E9CE4 wds:Q36611362-E4C46E35-58EC-494A-B2E1-1E4025420EC5 wds:Q36611362-C126C2F2-544D-48AA-8BA2-A7B18A5CFCBA wds:Q36611362-03C85FC3-6E3F-4568-B051-D8E895028D68
wdt:P50
wd:Q56985334 wd:Q66725450 wd:Q106513128 wd:Q89450189 wd:Q98207066
p:P1476
wds:Q36611362-4B959ADD-27F3-4AD7-9792-BF5F4BF887EF
wdt:P1476
Racial-ethnic differences in incident olanzapine use after an FDA advisory for patients with schizophrenia
p:P304
wds:Q36611362-DC6567BC-4DDD-46D5-B6E8-84F82FF9FB55
wdt:P304
83-87
p:P31
wds:Q36611362-614E4FB6-A228-467C-ABDA-8781123EFF95
wdt:P31
wd:Q13442814
p:P921
wds:Q36611362-4E1704EA-EF9A-478B-927E-85BBF0561519
wdt:P921
wd:Q41112
p:P698
wds:Q36611362-404B69AC-3B8F-4C06-B39E-9F3921A2C5BD
wdtn:P698
n11:23280461
wdt:P698
23280461
p:P1433
wds:Q36611362-B2769D6E-767A-4B6C-9460-958E6DC2F741
wdt:P1433
wd:Q7256227
p:P433
wds:Q36611362-AF2C6BB8-79DD-4AE8-A6EF-04E510DC85AC
p:P478
wds:Q36611362-AAD29E57-E8C2-49E6-88F9-6117625B5D51
wdt:P433
1
wdt:P478
64
p:P356
wds:Q36611362-51FD9254-FE72-4083-974E-F044DB5E285A
wdtn:P356
n10:APPI.PS.201200002
wdt:P356
10.1176/APPI.PS.201200002
p:P5875
wds:Q36611362-B84FDEDA-596F-486B-B53D-F5D3C489D737
wdt:P5875
234031854
p:P932
wds:Q36611362-C12E0C3F-CFE0-4FBB-BA83-C4EF4E62687E
wdt:P932
3572912